Cleared Traditional

K132810 - GLADIATOR ELITE PTA BALLOON DILATATION CATHETER

K132810 is an FDA 510(k) clearance for GLADIATOR ELITE PTA BALLOON DILATATION ..., manufactured by Boston Scientific Corp. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 172-day FDA review.

K132810 · Boston Scientific Corp · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
172d
Days
Class 2
Risk

K132810 is an FDA 510(k) clearance for the GLADIATOR ELITE PTA BALLOON DILATATION CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Boston Scientific Corp (Maple Grove, US). The FDA issued a Cleared decision on February 28, 2014 after a review of 172 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K132810

510(k) Number K132810 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 09, 2013
Decision Date February 28, 2014
Days to Decision 172 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d slower than avg
Panel avg: 125d · This submission: 172d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 388
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K132810.
FLASH OSTIAL SYSTEM OTW-7.0MMX17MMX135CM, FLASH OSTIAL SYSTEM OTW-7.0MMX17MMX80CM
K133861 · Ostial Corporation · Jul 2014
ARROW GPSCATH BALLOON DILATATION CATHETER
K140351 · Hotspur Technologies,Inc Subsidiary of Teleflex ME · Jul 2014
SABER PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY DILATATION CATHETER
K133843 · Cordis Corporation · Jun 2014
PROTEUS PTA BALLOON CATHETER WITH EMBOLIC CAPTURE FEATURE
K133043 · Angioslide, Ltd. · Dec 2013
ADVANCE 34LP LOW PROFILE PTA BALLOON DILATATION CATHETER
K132020 · Cook, Inc. · Oct 2013
STERLING OVER-THE-WIRE (OTW) PTA BALLOON DILATATION CATHETER
K132430 · Boston Scientific Corp · Oct 2013
K132810 · GLADIATOR ELITE PTA BALLOON DILATATION CATHETER
Download PDF FDA Summary Boston Scientific Corp